Mallory Shillinger, DO | |
120 Hawthorne Park, Athens, GA 30606-2147 | |
(706) 353-8700 | |
Not Available |
Full Name | Mallory Shillinger |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 8 Years |
Location | 120 Hawthorne Park, Athens, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023466570 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 208D00000X (Florida) | Secondary |
207R00000X | Internal Medicine | 84754 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Encompass Health Home Health | Elberton, GA | Home health agency |
Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
St Mary's Hospital | Athens, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Piedmont Athens Primary Care Llc | 0648520841 | 67 |
News Archive
Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.
VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that the U.S. Patent Office has granted patent number US 7,465,449, which broadly covers monoclonal antibodies to integrin ávâ6, including compositions related to its lead product, STX-100.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
Patients diagnosed with post-traumatic stress disorder (PTSD) have a significantly higher risk of developing insulin resistance and metabolic syndrome, placing them at greater risk for heart disease and diabetes, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers say public health interventions are urgently needed to prevent PTSD-related metabolic disorder at its early, reversible stage.
› Verified 1 days ago
Entity Name | Piedmont Athens Primary Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245746783 PECOS PAC ID: 0648520841 Enrollment ID: O20180910002202 |
News Archive
Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.
VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that the U.S. Patent Office has granted patent number US 7,465,449, which broadly covers monoclonal antibodies to integrin ávâ6, including compositions related to its lead product, STX-100.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
Patients diagnosed with post-traumatic stress disorder (PTSD) have a significantly higher risk of developing insulin resistance and metabolic syndrome, placing them at greater risk for heart disease and diabetes, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers say public health interventions are urgently needed to prevent PTSD-related metabolic disorder at its early, reversible stage.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mallory Shillinger, DO Po Box 117264, Atlanta, GA 30368-7264 Ph: (706) 369-5440 | Mallory Shillinger, DO 120 Hawthorne Park, Athens, GA 30606-2147 Ph: (706) 353-8700 |
News Archive
Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.
VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that the U.S. Patent Office has granted patent number US 7,465,449, which broadly covers monoclonal antibodies to integrin ávâ6, including compositions related to its lead product, STX-100.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
Patients diagnosed with post-traumatic stress disorder (PTSD) have a significantly higher risk of developing insulin resistance and metabolic syndrome, placing them at greater risk for heart disease and diabetes, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers say public health interventions are urgently needed to prevent PTSD-related metabolic disorder at its early, reversible stage.
› Verified 1 days ago
Bannur Ramanna Nandeesh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-5076 | |
Krupal Jay Hari, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 242 King Avenue, Suite 210, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-475-1790 | |
Mr. Ashwin Thatti, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 500c, Athens, GA 30606 Phone: 706-546-7484 | |
Dr. Stephen William Wilde, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 Sunset Dr, Suite 501, Athens, GA 30606 Phone: 706-208-0065 Fax: 706-459-8693 | |
Dr. James S Miller, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-546-1787 | |
Dr. Paul Peteet, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Diana T Blake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2470 Daniells Bridge Rd Ste 231, Athens, GA 30606 Phone: 706-769-3362 Fax: 706-769-5675 |